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P189
Collagen hydrolysate supplementation stimulates proteoglycan 
metabolism and gene expression of articular chondrocytes
M. Schunck1, C.H. Schulze2, S. Oesser1;
1Collagen Research Institute, CRI, Kiel, Germany, 2General Surgery 
And Traumatology, Klinikum Elmshorn, Elmshorn, Germany
Purpose: Over the past years hydrolyzed collagen has been used 
in the treatment of OA and positive effects on joint health were 
demonstrated in clinical studies. The therapeutic mechanism, 
IPXFWFSJTTUJMMBTVCKFDUPGTDJFOUJ¾DEJTDVTTJPO5IFBJNPGUIJTTUVEZ
XBTUPJOWFTUJHBUFUIFJO¿VFODFPGBTQFDJ¾D$PMMBHFO)ZESPMZTBUF
(CH) on the proteoglycan metabolism of the extracellular matrix 
(ECM) of chondrocytes. 
Methods and Materials: Primary porcine articular and human femoral 
chondrocytes were cultured under reduced oxygen conditions. The 
culture medium was supplemented with various concentrations 
of CH. At different time points of the culture period the amount of 
TFDSFUFE BOE DFMMBTTPDJBUFE QSPUFPHMZDBOT 	1(T
 XFSF RVBOUJ¾FE
by measuring [35]S-sulphate incorporation. Total proteoglycan 
CJPTZOUIFTJTXBTNFBTVSFECZTQFDJ¾DTUBJOJOHPGTVMQIBUFHSPVQT
with Alcian blue. Moreover, the expression of aggrecan was 
determined by Northern Blot analysis and the amount of aggrecan in 
the ECM was analyzed via Western Blotting. 
Results: Supplementation of the culture medium with CH resulted 
JOBTUBUJTUJDBMMZTJHOJ¾DBOU	Q<0.05) increase of total PG synthesis. 
5IF BNPVOU PG TFDSFUFE BOE DFMMBTTPDJBUFE 1(TXBT TJHOJ¾DBOUMZ
increased up to 1.6-fold after CH treatment compared with the 
control cells. In particular, administration of CH was associated 
XJUI B TUBUJTUJDBMMZ TJHOJ¾DBOU JODSFBTF 	Q<0.05) of aggrecan RNA 
expression and a pronounced accumulation of aggrecan in the ECM. 
Conclusions: These results indicate a stimulatory effect of CH on the 
metabolism of proteoglycans in porcine and human chondrocytes. 
Thus CH may be helpful reducing degenerative changes of the ECM 
by stimulating anabolic processes in cartilage tissue. 
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The use of recombinant human type II collagen gel for cartilage 
tissue engineering
H.J. Pulkkinen1, V. Tiitu1, P. Valonen1, E. Hämäläinen2, J. Koivurinta3,
M. Lammi4, I. Kiviranta5;
1Institute Of Biomedicine, Anatomy, University of Kuopio, Kuopio, 
Finland, 2Bioprocess Engineering Laboratory, University of Oulu, 
Oulu, Finland, 3Europe, Fibrogen, Helsinki, Finland, 4Anatomy,
University of Kuopio, Kuopio, Finland, 5Jyväskylä Central Hospital, 
Jyväskylä Central Hospital, Jyväskylä, Finland
Purpose: The use of 3-D scaffold can promote cell proliferation 
and matrix production in chondrocyte cultivation. In this study 
recombinant human (rh) type II collagen gel was tested as a scaffold 
material for chondrocytes in in vitro conditions and in vivo under the 
skin of nude mice. 
Methods and Materials: Primary bovine chondrocytes were added 
to rh type II collagen solution and the mixture was allowed to gel in 
an incubator. Excess liquid was removed and the gels were grown 
in vitro for maximum of 4 weeks. For in vivo studies the collagen 
gel containing chondrocytes was injected subcutaneously into the 
backs of nude mice and cultivated for 6 weeks. 
Results: The viability assay demonstrated that cells were growing well 
in the gels during the whole 4-week-period. The matrix production 
increased during the cultivation, which was shown in increased 
uronic acid levels Elevated mRNA production of type II collagen and 
aggrecan were detected with real-time PCR. The histological analysis 
showed that the cells were rounded and evenly distributed in the 
gels, and the amount of cells and matrix increased during cultivation. 
In vivo study revealed that the cells in the collagen gel produced a 
piece of hyaline-like cartilage tissue when grown in the mice for 6 
weeks. Histologically the cells were rounded and were surrounded 
by matrix stained intensively with toluidine blue. 
Conclusions: These results implicate that recombinant human type 
II collagen gel could be useful in cartilage tissue engineering, as the 
cells distribute evenly, proliferate and produce matrix when grown 
in the material. 
P191
Hypertrophic differentiation of chondrocytes - enhancing 
properties of in-vitro generated cartilage
M. Rutgers1, D.B. Saris2, K. Auw Yang3, S. Schoots1, K. Sasaguri4, R. 
Castelein1, L.B. Creemers1, W.J.A. Dhert1;
1Orthopaedics, University Medical Center Utrecht, Utrecht, 
Netherlands, 2Orthopaedics, University Medical Center, Utrecht, 
Utrecht, Netherlands, 3,, 4Orthopaedics, Tokai University, Kanagawa, 
Japan
Purpose: Optimising conditions for Autologous Chondrocyte 
Transplantation (ACT) may enhance quality of regenerated cartilage. 
Hypertrophic differentiation, during which markers for osteogenesis 
are expressed, is undesirable in articular cartilage regeneration. 
$PSFCJOEJOH GBDUPS BMGB 	$CGB PS 36/9
 JT BO FBSMZ TQFDJ¾D
marker for hypertrophic differentiation. Detection- and inhibition of 
this transcription factor may lead to generation of cartilage of better 
quality. 
Methods and Materials: Cartilage was harvested from unaffected 
knee joints of two tissue donors. After isolation and expansion, 
chondrocytes were redifferentiated in pellets, on uncoated Millicell®
¾MUFSTPSPO¾MUFSTDPBUFEXJUIDPMMBHFOUZQF*PSDPMMBHFOUZQF**GPS
EBZT5IFFGGFDUPG¾MUFSDPBUJOHPOIZQFSUSPQIJDEJGGFSFOUJBUJPO
of regenerated cartilage was analysed by immunohistochemistry for 
Cbfa1. 
Results: #PUIJOQFMMFUBTXFMMBTJO¾MUFSDVMUVSFT$CGBXBTQSFTFOU
Staining was mainly localized to the nucleus of the chondrocytes but 
was also observed in the cytoplasm of the cells. In both pellets as 
XFMMBT¾MUFSTCFUXFFOBOEPGUIFDFMMTTUBJOFEQPTJUJWF
for Cbfa-1. The percentage of Cbfa-1 positive cells varied between 
the two donors. Also, Cbfa-1 expression differed between the various 
UZQFTPG¾MUFSDPBUJOHT
Conclusions: 'PS UIF¾STU UJNF UIFFYQSFTTJPOPG$CGB JO JO WJUSP
EJGGFSFOUJBUFEDBSUJMBHFUJTTVFJTEFNPOTUSBUFE"MUIPVHIUIF¾MUFS°
regenerated tissue has previously been shown to be of better quality 
as compared to the pellet model, hypertrophic changes still occur. 
5ZQFPG¾MUFSDPBUJOHEPFTOPUJO¿VFODFIZQFSUSPQIJDEJGGFSFOUJBUJPO
BMUIPVHI UIFSF TFFNT UP CF B OPOTJHOJ¾DBOU USFOE UPXBSET
BEWBOUBHFGPSDPMMBHFOUZQF**DPBUFE¾MUFST
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Aggrecan gene expression as a potency marker for matrix-induced 
autologous chondroctye implantation (MACI)
S. Rapko1, A. Parker2, C. Mortelliti3, S.J. Duguay1;
1Genzyme Biosurgery, Cambridge, MA, United States of America, 
2Biosurgery, Genzyme, Cambridge, United States of America, 3Mts,
Genzyme Biosurgery, Cambridge, United States of America
Purpose: Abundant aggrecan gene expression is typically observed 
in cell cultures derived from adult human cartilage, as well as those 
GSPNTZOPWJVN SFMBUJWF UPPUIFS DVMUVSFTTVDIEFSNBM¾CSPCMBTUT
Primary chondrocytes were observed to express aggrecan protein 
as measured by ELISA. Aggrecan protein declined with subsequent 
passaging, however aggrecan mRNA remained abundant relative to 
EFSNBM ¾CSPCMBTUT $IPOESPHFOJD EJGGFSFOUJBUJPO PG UIJSE QBTTBHF
NPOPMBZFS DIPOESPDZUFT BOE TZOPWJBM ¾CSPCMBTUT CVU OPU EFSNBM
¾CSPCMBTUT XBT PCTFSWFE VQPO BMHJOBUF CFBE DVMUVSF 5IFTF
observations indicated a correlation between aggrecan gene 
expression and the capacity for chondrogenic differentiation. To test 
whether this characteristic was retained during culture on porcine 
derived scaffold, the various cell types were tested for aggrecan 
gene expression. 
Methods and Materials: Real-time quantitative RT-PCR. 
Results: The testing revealed that MACI cultured chondrocytes and 
TZOPWJBM ¾CSPCMBTUT EJE FYQSFTT IJHIFS MFWFMT PG BHHSFDBO N3/"
UIBOEFSNBM¾CSPCMBTUTJOUIFTFDPOTUSVDUT$IPOESPDZUFTSFDMBJNFE
from the MACI scaffold expressed abundant type II collagen mRNA 
and formed type II collagen protein in pellet culture, while neither 
XBT PCTFSWFE XJUI EFSNBM ¾CSPCMBTUT 5ZQF * DPMMBHFO HFOF
expression in pellet cultures was lower in chondrocytes than that 
PG EFSNBM ¾CSPCMBTUT 3FDMBJNFE DIPOESPDZUFT HSPXO JO BMHJOBUF
culture upregulated type II collagen and aggrecan gene expression 
UPBCVOEBOUMFWFMTXIJMFEFSNBM¾CSPCMBTUDVMUVSFTEJEOPUFYQSFTT
these markers. 
Conclusions: MACI chondrocytes retain the ability to redifferentiate 
as judged by chondrogenic differentiation in alginate and pellet 
culture systems. Aggrecan gene expression in MACI constructs was 
indicative of this ability.
